BIOMAT Database Logo BIOMAT Database Logo

[Clinical studies on Suncefal (cefpiramide) concentration in prostatic tissue and bladder wall]. 1988

N Okishio, and M Yonezu, and S Hanai, and K Ishiguro, and M Yanaoka, and Y Naide
Department of Urology, Shizuoka Red Cross Hospital.

The cefpiramide (CPM) concentration in prostatic tissue of 19 patients with benign prostatic hypertrophy and bladder wall of 2 patients with bladder tumors was measured, after 2 g of CPM was administered intravenously by bolus technique prior to operation. Prostatic tissue level was 28.4 to 131 micrograms/g and tissue to serum ratio 0.15 to 0.63 at 12 min. to 220 min. after administration. The T1/2 of CPM in prostatic tissue was 3.29 hours. The bladder wall level was high at both determinations. CPM level in prostatic tissue and bladder wall covered the minimum inhibitory concentration of many bacteria detected from the infected sites. Therefore, CPM which has a strong antimicrobial activity can be considered as a highly useful antibiotic for the treatment of postoperative infections.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011467 Prostate A gland in males that surrounds the neck of the URINARY BLADDER and the URETHRA. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the PUBIC SYMPHYSIS, above the deep layer of the triangular ligament, and rests upon the RECTUM. Prostates
D011470 Prostatic Hyperplasia Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both. Adenoma, Prostatic,Benign Prostatic Hyperplasia,Prostatic Adenoma,Prostatic Hyperplasia, Benign,Prostatic Hypertrophy,Prostatic Hypertrophy, Benign,Adenomas, Prostatic,Benign Prostatic Hyperplasias,Benign Prostatic Hypertrophy,Hyperplasia, Benign Prostatic,Hyperplasia, Prostatic,Hyperplasias, Benign Prostatic,Hypertrophies, Prostatic,Hypertrophy, Benign Prostatic,Hypertrophy, Prostatic,Prostatic Adenomas,Prostatic Hyperplasias, Benign,Prostatic Hypertrophies
D001743 Urinary Bladder A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION. Bladder,Bladder Detrusor Muscle,Detrusor Urinae,Bladder Detrusor Muscles,Bladder, Urinary,Detrusor Muscle, Bladder,Detrusor Muscles, Bladder
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

N Okishio, and M Yonezu, and S Hanai, and K Ishiguro, and M Yanaoka, and Y Naide
[Clinical studies on cefmenoxine concentration in prostatic tissue and bladder wall].
May 1984, The Japanese journal of antibiotics,
N Okishio, and M Yonezu, and S Hanai, and K Ishiguro, and M Yanaoka, and Y Naide
[Concentration of cefotiam in the human prostatic tissue and bladder wall].
February 1984, The Japanese journal of antibiotics,
N Okishio, and M Yonezu, and S Hanai, and K Ishiguro, and M Yanaoka, and Y Naide
[Clinical studies on cefpiramide].
September 1985, The Japanese journal of antibiotics,
N Okishio, and M Yonezu, and S Hanai, and K Ishiguro, and M Yanaoka, and Y Naide
[Prostatic tissue levels of cefpiramide (CPM)].
June 1988, Hinyokika kiyo. Acta urologica Japonica,
N Okishio, and M Yonezu, and S Hanai, and K Ishiguro, and M Yanaoka, and Y Naide
[Clinical studies of cefpiramide in obstetrics and gynecology].
August 1985, The Japanese journal of antibiotics,
N Okishio, and M Yonezu, and S Hanai, and K Ishiguro, and M Yanaoka, and Y Naide
[Clinical studies on cefpiramide in the field of obstetrics and gynecology].
August 1985, The Japanese journal of antibiotics,
N Okishio, and M Yonezu, and S Hanai, and K Ishiguro, and M Yanaoka, and Y Naide
The ampicillin concentration in prostatic tissue and prostatic fluid.
January 1967, Urologia internationalis,
N Okishio, and M Yonezu, and S Hanai, and K Ishiguro, and M Yanaoka, and Y Naide
[Ofloxacin concentration in prostatic tissue].
December 1993, Hinyokika kiyo. Acta urologica Japonica,
N Okishio, and M Yonezu, and S Hanai, and K Ishiguro, and M Yanaoka, and Y Naide
Ectopic prostatic tissue in bladder.
October 1967, The Journal of urology,
N Okishio, and M Yonezu, and S Hanai, and K Ishiguro, and M Yanaoka, and Y Naide
Bladder wall tension in benign prostatic hypertrophy.
May 1977, Investigative urology,
Copied contents to your clipboard!